Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | KIT |
Variant | V560G |
Impact List | missense |
Protein Effect | gain of function |
Gene Variant Descriptions | KIT V560G lies within the juxtamembrane domain (exon 11) of the Kit protein (PMID: 9438854). V560G confers a gain of function to Kit, as indicated by constitutive phosphorylation of Kit and activation of the Jak/Stat pathway (PMID: 7691885, PMID: 23777495, PMID: 31484543), and leads to mislocalization of Kit to endolysosomes in cell culture (PMID: 31484543). |
Associated Drug Resistance | |
Category Variants Paths |
KIT mutant KIT act mut KIT V560G KIT mutant KIT exon11 KIT V560G |
Transcript | NM_000222.3 |
gDNA | chr4:g.54727447T>G |
cDNA | c.1679T>G |
Protein | p.V560G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_005265740.1 | chr4:g.54727444T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
XM_017008178.1 | chr4:g.54727447T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
XM_005265740 | chr4:g.54727444T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
NM_001385284.1 | chr4:g.54727444T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
NM_000222.3 | chr4:g.54727447T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
NM_001385285.1 | chr4:g.54727447T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
XM_005265741 | chr4:g.54727444T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
XM_017008178 | chr4:g.54727447T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
NM_001385290.1 | chr4:g.54727444T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
XM_005265741.1 | chr4:g.54727444T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
NM_000222 | chr4:g.54727447T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
NM_000222.2 | chr4:g.54727447T>G | c.1679T>G | p.V560G | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|